1.09-00 Welcome
2.08-00 Agenda

2.08-03 Review and Decisions on the future of Working Groups
2.08-03.0 Working Group Review Summary

2.08-03.1 A DOTS Expansion

2.08-03.1 A1 GLI

2.08-03.1 A2 TB & Poverty

2.08-03.1 A3 Childhood TB

2.08-03.1 A4 PPM

2.08-03.1 B TB HIV

2.08-03.1 B1 TB Infection Control

2.08-03.1 C MDR TB

2.08-03.1 D ACSM

2.08-03.1 D1 ACSM Future Discussion Note

2.08-03.1 D1 ACSM Global level

2.08-03.1 D2 ACSM Country level

2.08-03.1 D2 Advocacy Advisory Committee and Network

2.08-03.1 E New Drugs

2.08-03.1 F New Diagnostics

2.08-03.1 G New Vaccines

2.08-04 Global Fund and Collaboration with TB TEAM
2.08-04.0 Global Fund and TB Team Summary

2.08-07 Impact Assessment Taskforce
2.08-07.0 Impact Measurement Summary

2.08-08 Engaging the Business Sector Constituency
2.08-08.0 Business Engagement Summary

2.08-09 MDR-TB Meeting of 27 high burden countries
2.08-09.0 MDR Meeting Summary

2.08-12 Global Plan Progress Report
2.08-12.0 Global Plan Progress Summary

2.08-14 Implementation of the Work Plan 2008
2.08-14.0 Work Plan Implementation Summary

2.08-14.1 Workplan Implemenation Technical Explanation

2.08-14.2A Secretariat Workplan Implementation

2.08-14.2B GDF Workplan Implementation

2.08-14.3 Ex Comm Minutes Evaluation

2.08-15 Closing Session
2.08-15.0 Closing Session
